Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
43.2M
-
Shares change
-
-800K
-
Total reported value, excl. options
-
$973M
-
Value change
-
-$14.1M
-
Number of buys
-
46
-
Number of sells
-
-26
-
Price
-
$22.51
Significant Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q2 2021
86 filings reported holding PCVX - Vaxcyte, Inc. - COMMON STOCK as of Q2 2021.
Vaxcyte, Inc. - COMMON STOCK (PCVX) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.2M shares
of 130M outstanding shares and own 33.27% of the company stock.
Largest 10 shareholders include FMR LLC (7.71M shares), TPG Group Holdings (SBS) Advisors, Inc. (4.56M shares), Abingworth LLP (4.17M shares), JANUS HENDERSON GROUP PLC (4.12M shares), RA CAPITAL MANAGEMENT, L.P. (3.87M shares), VANGUARD GROUP INC (2.85M shares), BlackRock Inc. (2.35M shares), FRAZIER MANAGEMENT LLC (2.31M shares), Medicxi Ventures Management (Jersey) Ltd (1.89M shares), and STATE STREET CORP (1.5M shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.